M5717+pyronaridine
Product development
-
Patient exploratory
Merck KGaA/Shin Poong
Asexual blood stages
Transmission reduction
Chemoprevention
Uncomplicated malaria treatments and resistance management (TPP-1)
Product vision |
|
MOA |
|
Key features |
|
Challenges |
|
Status |
|
Next milestone | |
Previously |
|
Project Director |
|